1. Different Mismatch Concepts for Magnetic Resonance Imaging–Guided Thrombolysis in Unknown Onset Stroke
- Author
-
Matthias Endres, Jochen B. Fiebach, Anke Wouters, Bastian Cheng, Soren Christensen, Robin Lemmens, Christian Gerloff, Patrick Dupont, Keith W. Muir, Martin Ebinger, Salvador Pedraza, Florent Boutitie, Claus Z Simonsen, Götz Thomalla, Norbert Nighoghossian, Vincent Thijs, Lauranne Scheldeman, University Hospitals Leuven [Leuven], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Flanders Make [Leuven], Flanders Make, Hospices Civils de Lyon (HCL), Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), GrayNumber Analytics [Lomma, Sweden], Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), German Research Center for Neurodegenerative Diseases - Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), University of Glasgow, Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé (CREATIS), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospital Universitari de Girona Doctor Josep Trueta [Girona, Spain], Aarhus University Hospital, Florey Institute of Neuroscience and Mental Health [Melbourne, Victoria, Australia], Austin Health, WAKE-UP Investigators, CarMeN, laboratoire, Université Jean Monnet [Saint-Étienne] (UJM)-Hospices Civils de Lyon (HCL)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Male ,medicine.medical_treatment ,Image Processing ,[SDV]Life Sciences [q-bio] ,Perfusion scanning ,Fluid-attenuated inversion recovery ,Brain Ischemia ,030218 nuclear medicine & medical imaging ,0302 clinical medicine ,Modified Rankin Scale ,methods [Image Processing, Computer-Assisted] ,Image Processing, Computer-Assisted ,therapeutic use [Fibrinolytic Agents] ,diagnostic imaging [Stroke] ,Thrombolytic Therapy ,Stroke ,medicine.diagnostic_test ,Thrombolysis ,adverse effects [Fibrinolytic Agents] ,Middle Aged ,3. Good health ,drug therapy [Stroke] ,[SDV] Life Sciences [q-bio] ,therapeutic use [Tissue Plasminogen Activator] ,Treatment Outcome ,Neurology ,Tissue Plasminogen Activator ,Predictive value of tests ,Cardiology ,drug therapy [Brain Ischemia] ,Tissue Plasminogen Activator/adverse effects/therapeutic use ,Female ,WAKE-UP Investigators ,medicine.medical_specialty ,Perfusion Imaging ,03 medical and health sciences ,Fibrinolytic Agents ,Double-Blind Method ,Predictive Value of Tests ,Internal medicine ,Stroke/*diagnostic imaging/*drug therapy ,medicine ,Humans ,cardiovascular diseases ,ddc:610 ,Fibrinolytic Agents/adverse effects/therapeutic use ,adverse effects [Tissue Plasminogen Activator] ,Aged ,Thrombolytic Therapy/adverse effects/*methods ,business.industry ,Magnetic resonance imaging ,methods [Thrombolytic Therapy] ,medicine.disease ,adverse effects [Thrombolytic Therapy] ,Confidence interval ,Computer-Assisted/*methods ,Brain Ischemia/diagnostic imaging/drug therapy ,Diffusion Magnetic Resonance Imaging ,diagnostic imaging [Brain Ischemia] ,Neurology (clinical) ,business ,030217 neurology & neurosurgery - Abstract
OBJECTIVE: To explore the prevalence of the perfusion-weighted imaging (PWI)-diffusion-weighted imaging (DWI) mismatch and response to intravenous thrombolysis in the WAKE-UP trial. METHODS: We performed a prespecified post hoc analysis of ischemic stroke patients screened for DWI-fluid-attenuated inversion recovery (FLAIR) mismatch in WAKE-UP who underwent PWI. We defined PWI-DWI mismatch as ischemic core volume 10ml, and mismatch ratio > 1.2. Primary efficacy end point was a modified Rankin Scale score of 0-1 at 90 days, adjusted for age and symptom severity. RESULTS: Of 1,362 magnetic resonance imaging-screened patients, 431 underwent PWI. Of these, 57 (13%) had a double mismatch, 151 (35%) only a DWI-FLAIR mismatch, and 54 (13%) only a PWI-DWI mismatch. DWI-FLAIR mismatch was more prevalent than PWI-DWI mismatch (48%, 95% confidence interval [CI] = 43-53% vs 26%, 95% CI = 22-30%; p
- Published
- 2020